m.3243A (8) Lindroos, Markus M a Majamaa, Kari a,b Tura, Andrea c Mari, Andrea c Kalliokoski, Kari K a Taittonen, Markku T a Iozzo, Patricia a,d Nuutila, Pirjo a a TURKU UNIVERSITY HOSPITAL (Finland) b UNIVERSITY OF OULU (Finland) c CNR (Italy) d INSTITUTE OF CLINICAL PHYSIOLOGY (Italy)

Diabetes

Volumn 58, Issue 3, 2009, Pages 543-549

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; MITOCHONDRIAL DNA; ADENINE; ANTIDIABETIC AGENT; FLUORINE; FLUORODEOXYGLUCOSE F 18; GUANINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE MUTATION; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MUSCLE PERFUSION; ORAL GLUCOSE TOLERANCE TEST; PANCREAS INSUFFICIENCY; PANCREAS ISLET BETA CELL; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SKELETAL MUSCLE; GENETICS; GLUCOSE CLAMP TECHNIQUE; MIDDLE AGED; PANCREAS ISLET; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENINE; ADULT; DIABETES MELLITUS; DNA, MITOCHONDRIAL; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GLUCOSE CLAMP TECHNIQUE; GUANINE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; POLYMORPHISM, SINGLE NUCLEOTIDE; POSITRON-EMISSION TOMOGRAPHY; REFERENCE VALUES;

EID: 62749102812     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-0981     Document Type: Article

References (48)

1. Iozzo P, Hállsten K, Oikonen V, Virtanen KA, Kemppainen J, Solin O, Ferrannini E, Knuuti J, Nuutila P: Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control. J Clin Endocrinol Metab 88:2055-2060, 2003
2. Virtanen KA, Lönnroth P, Parkkola R, Peltoniemi P, Asola M, Viljanen T, Tolvanen T, Knuuti J, Ronnemaa T, Huupponen R, Nuutila P: Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese and obese humans. J Clin Endocrinol Metab 87:3902-3910, 2002
3. Beck-Nielsen H, Vaag A, Poulsen P, Gaster M: Metabolic and genetic influence on glucose metabolism in type 2 diabetic subjects: experiences from relatives and twin studies. Best Pract Res Clin Endocrinol Metab 17:445-467, 2003
4. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG: Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322:223-228, 1990
5. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ, Goldfine AB, Mun E, DeFronzo R, Finlayson J, Kahn CR, Mandarino LJ: Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 100:8466-8471, 2003
6. Scheuermann-Freestone M, Madsen PL, Manners D, Blamire AM, Buckingham RE, Styles P, Radda GK, Neubauer S, Clarke K: Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 107:3040-3046, 2003
7. Befroy DE, Petersen KF, Dufour S, Mason GF, de Graaf RA, Rothman DL, Shulman GI: Impaired mitochondrial substrate oxidation in muscle of insulin- resistant offspring oftype 2 diabetic patients. Diabetes 56:1376-1381, 2007
8. Festa A, Williams K, D'Agostino R Jr, Wagenknecht LE, Haffner SM: The natural course of β-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes 55:1114-1120, 2006
9. Xiang AH, Wang C, Peters RK, Trigo E, Kjos SL, Buchanan TA: Coordinate changes in plasma glucose and pancreatic β-cell function in Latino women at high risk for type 2 diabetes. Diabetes 55:1074-1079, 2006
10. Perry JR, Frayling TM: New gene variants alter type 2 diabetes risk predominantly through reduced beta-cell function. Curr Opin Clin Nutr Metab Care 11:371-377, 2008
11. Zeviani M, Di Donato S: Mitochondrial disorders. Brain 127:2153-2172,2004
12. Ukropcova B, Sereda O, de Jonge L, Bogacka I, Nguyen T, Xie H, Bray GA, Smith SR: Family history of diabetes links impaired substrate switching and reduced mitochondrial content in skeletal muscle. Diabetes 56:720727, 2007
13. Wiederkehr A, Wollheim CB: Minireview: implication of mitochondria in insulin secretion and action. Endocrinology 147:2643-2649, 2006
14. Hirai M, Suzuki S, Onoda M, Hinokio Y, Hirai A, Ohtomo M, Chiba M, Kasuga S, Hirai S, Satoh Y, Akai H, Miyabayashi S, Toyota T: Mitochondrial deoxyribonu- cleic acid 3256C-T mutation in a Japanese family with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:992-994, 1998
15. Tawata M, Hayashi JI, Isobe K, Ohkubo E, Ohtaka M, Chen J, Aida K, Onaya T: A new mitochondrial DNA mutation at 14577 T/C is probably a major pathogenic mutation for maternally inherited type 2 diabetes. Diabetes 49:1269-1272, 2000
16. Guillausseau PJ, Massin P, Dubois-LaForgue D, Timsit J, Virally M, Gin H, Bertin E, Blickle JF, Bouhanick B, Cahen J, Caillat-Zucman S, Charpentier G, Chedin P, Derrien C, Ducluzeau PH, Grimaldi A, Guerci B, Kaloustian E, Murat A, Olivier F, Paques M, Paquis-Flucklinger V, Porokhov B, Samuel- Lajeunesse J, Vialettes B: Maternally inherited diabetes and deafness: a multicenter study. Ann Intern Med 134:721-728, 2001
17. Chinnery PF, Elliott C, Green GR, Rees A, Coulthard A, Turnbull DM, Griffiths TD: The spectrum of hearing loss due to mitochondrial DNA defects. Brain 123:82-92, 2000
18. Velho G, Byrne MM, Clement K, Sturis J, Pueyo ME, Blanche H, Vionnet N, Fiet J, Passa P, Robert JJ, Polonsky KS, Froguel P: Clinical phenotypes, insulin secretion, and insulin sensitivity in kindreds with maternally inherited diabetes and deafness due to mitochondrial tRNALeu(UUR) gene mutation. Diabetes 45:478-487, 1996
19. Suzuki Y, Iizuka T, Kobayashi T, Nishikawa T, Atsumi Y, Kadowaki T, Oka Y, Kadowaki H, Taniyama M, Hosokawa K, Asahina T, Matsuoka K: Diabetes mellitus associated with the 3243 mitochondrial tRNA(Leu)(UUR) mutation: insulin secretion and sensitivity. Metabolism, 46:1019-1023, 1997
20. Suzuki S, Hinokio Y, Hirai S, Onoda M, Matsumoto M, Ohtomo M, Kawasaki H, Satoh Y, Akai H, Abe K: Pancreatic beta-cell secretory defect associated with mitochondrial point mutation of the tRNA(LEU(UUR)) gene: a study in seven families with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS). Diabetologia 37:818-825, 1994
21. Salles JE, Kasamatsu TS, Dib SA, Moises RS: Beta-cell function in individuals carrying the mitochondrial tRNA leu (UUR) mutation. Pancreas 34:133-137, 2007
22. Holmes-Walker DJ, Ward GM, Boyages SC: Insulin secretion and insulin sensitivity are normal in non-diabetic subjects from maternal inheritance diabetes and deafness families. Diabet Med 18:381-387, 2001
23. Gebhart SS, Shoffner JM, Koontz D, Kaufman A, Wallace D: Insulin resistance associated with maternally inherited diabetes and deafness. Metabolism 45:526-531, 1996
24. Bradie;ndle M, Lehmann R, Maly FE, Schmid C, Spinas GA: Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation. Diabetes Care 24:1253-1258, 2001
25. Majamaa K, Moilanen JS, Uimonen S, Remes AM, Salmela PI, KarppaM, Majamaa-Voltti KA, Rusanen H, Sorri M, Peuhkurinen KJ, Hassinen IE: Epidemiology of A3243G, the mutation for mitochondrial encephalomy- opathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. Am J Hum Genet 63:447-454, 1998
26. Tehard B, Saris WH, Astrup A, Martinez JA, Taylor MA, Barbe P, Rich- terova B, Guy-Grand B, Sorensen TI, Oppert JM: Comparison of two physical activity questionnaires in obese subjects: the NUGENOB study. Med Sci Sports Exerc 37:1535-1541, 2005
27. Vancauter E, Mestrez F, Sturis J, Polonsky KS: Estimation of insulin-secretion rates from C-peptide levels: comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368-377, 1992
28. Mari A, Tura A, Gastaldelli A, Ferrannini E: Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. Diabetes 51:S221-S226, 2002
29. Hällsten K, Virtanen KA, Lönnqvist F, Sipilä H, Oksanen A, Viljanen T, Rönnemaa T, Viikari J, Knuuti J, Nuutila P: Rosiglitazone but not met- formin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes. Diabetes 51: 3479-3485, 2002
30. Hamacher K, Coenen HH, Stocklin G: Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27:235-238, 1986
31. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223,1979
32. Hällsten K, Yki-Jadie;rvinen H, Peltoniemi P, Oikonen V, Takala T, Kemp- painen J, Laine H, Bergman J, Bolli GB, Knuuti J, Nuutila P: Insulin- and exercise-stimulated skeletal muscle blood flow and glucose uptake in obese men. Obes Res 11:257-265, 2003
33. Peltoniemi P, Lonnroth P, Laine H, Oikonen V, Tolvanen T, Grodie;nroos T, Strindberg L, Knuuti J, Nuutila P: Lumped constant for [(18)F]fluorode- oxyglucose in skeletal muscles of obese and nonobese humans. Am J Physiol Endocrinol Metab 279:E1122-E1130, 2000
34. Sutinen J, Yki-Jarvinen H: Increased resting energy expenditure, fat oxidation, and food intake in patients with highly active antiretroviral therapy-associated lipodystrophy. Am J Physiol Endocrinol Metab 292: E687-E692, 2007
35. Hochberg Y, Benjamini Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 57:289 -300, 1995
36. Kadie;die;rppadie; M, Herva R, Moslemi AR, Oldfors A, Kakko S, Majamaa K: Spectrum of myopathic findings in 50 patients with the 3243A
37. Koga Y, Akita Y, Junko N, Yatsuga S, Povalko N, Fukiyama R, Ishii M, Matsuishi T: Endothelial dysfunction in MELAS improved by l-arginine supplementation. Neurology 66:1766-1769, 2006
38. Maassen JA, Janssen GM, 'T Hart LM: Molecular mechanisms of mitochon- drial diabetes (MIDD). Ann Med 37:213-221, 2005
39. Jeppesen TD, Schwartz M, Olsen DB, Vissing J: Oxidative capacity correlates with muscle mutation load in mitochondrial myopathy. Ann Neurol 54:86-92, 2003
40. Kelley DE, He J, Menshikova EV, Ritov VB: Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51:2944-2950, 2002
41. Vydt TC, de Coo RF, Soliman OI, Ten Cate FJ, van Geuns RJ, Vletter WB,Schoonderwoerd K, van den Bosch BJ, Smeets HJ, Geleijnse ML: Cardiac involvement in adults with m.3243A
42. Heilbronn LK, Gan SK, Turner N, Campbell LV, Chisholm DJ: Markers of mitochondrial biogenesis and metabolism are lower in overweight and obese insulin-resistant subjects. J Clin Endocrinol Metab 92:1467-1473, 2007
43. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, Honma Y, Hayashi J: ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320:661-664, 2008
44. Hitomi H, Fukui T, Moriwaki K, Matsubara K, Sun GP, Rahman M,Nishiyama A, Kiyomoto H, Kimura S, Ohmori K, Abe Y, Kohno M: Synergistic effect of mechanical stretch and angiotensin II on superoxide production via NADPH oxidase in vascular smooth muscle cells. J Hyper- tens 24:1089-1095, 2006
45. Martin D, Bellanne-Chantelot C, Deschamps I, Froguel P, Robert JJ, Velho G: Long-term follow-up of oral glucose tolerance test-derived glucose tolerance and insulin secretion and insulin sensitivity indexes in subjects with glucokinase mutations (MODY2). Diabetes Care 31:1321-1323, 2008
46. Maassen JA, Romijn JA, Heine RJ: Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: a new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus. Diabetologia 50:2036-2041, 2007
47. Otabe S, Yasuda K, Mori Y, Shimokawa K, Kadowaki H, Jimi A, Nonaka K, Akanuma Y, Yazaki Y, Kadowaki T: Molecular and histological evaluation of pancreata from patients with a mitochondrial gene mutation associated with impaired insulin secretion. Biochem Biophys Res Commun 259:149156, 1999
48. Maechler P, Carobbio S, Rubi B: In beta-cells, mitochondria integrate and generate metabolic signals controlling insulin secretion. Int J Biochem Cell Biol 38:696-709, 2006